{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:39:48Z","timestamp":1773272388231,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund (STDF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejphar.2011.08.041","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T07:22:44Z","timestamp":1315639364000},"page":"593-600","source":"Crossref","is-referenced-by-count":31,"title":["Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis"],"prefix":"10.1016","volume":"670","author":[{"given":"Mohamed E.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal E.","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.08.041_bb0005","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","article-title":"Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis","volume":"22","author":"Akhmetshina","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0003-2697(83)90580-8","article-title":"A rapid biuret assay for protein of whole fatty tissues","volume":"129","author":"Beyer","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0015","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0006-2952(99)00407-4","article-title":"Effect of silymarin on biliary bile salt secretion in the rat","volume":"59","author":"Crocenzi","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 5","key":"10.1016\/j.ejphar.2011.08.041_bb0035","doi-asserted-by":"crossref","first-page":"v10","DOI":"10.1093\/rheumatology\/ken276","article-title":"Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis","volume":"47","author":"Distler","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.phymed.2009.02.002","article-title":"A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis","volume":"16","author":"El-Kamary","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0045","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0050","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis\u2014fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0055","doi-asserted-by":"crossref","first-page":"d69","DOI":"10.2741\/887","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"8","author":"Gabele","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/37.3.2465335","article-title":"Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats","volume":"37","author":"Gascon-Barre","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0065","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/tx9701790","article-title":"Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation","volume":"11","author":"Gerard-Monnier","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2007.02.038","article-title":"Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests","volume":"381","author":"Gressner","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0075","first-page":"98","article-title":"Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam","volume":"30","author":"Hussain","year":"2009","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0080","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2003-37023","article-title":"Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB\/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses","volume":"69","author":"Johnson","year":"2003","journal-title":"Planta Med."},{"issue":"Suppl 3","key":"10.1016\/j.ejphar.2011.08.041_bb0090","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1440-1746.2006.04584.x","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0168-8278(02)00011-9","article-title":"Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality","volume":"36","author":"Li","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-beta and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0185","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.bmc.2010.08.026","article-title":"Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib","volume":"18","author":"Manley","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2893.2005.00636.x","article-title":"Silymarin treatment of viral hepatitis: a systematic review","volume":"12","author":"Mayer","year":"2005","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1440-1746.2006.04231.x","article-title":"Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models","volume":"21","author":"Natarajan","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.06.015","article-title":"Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term","volume":"44","author":"Neef","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/med.20115","article-title":"Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads","volume":"28","author":"Negi","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0145","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0160-5402(90)90061-O","article-title":"Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity","volume":"23","author":"Schierwagen","year":"1990","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ejphar.2011.08.041_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1472-8206.2010.00824.x","article-title":"Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression","volume":"25","author":"Shaker","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.taap.2011.02.004","article-title":"Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis","volume":"252","author":"Shaker","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0165","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ptr.879","article-title":"Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans","volume":"15","author":"Varga","year":"2001","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2011.08.041_bb0180","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6603170","article-title":"AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL","volume":"94","author":"Weisberg","year":"2006","journal-title":"Br. J. Cancer"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911009514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911009514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T05:53:08Z","timestamp":1543557188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911009514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":37,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0014299911009514"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.08.041","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}